UNITED THERAPEUTICS Corp financial data

Symbol
UTHR on Nasdaq
Industry
Pharmaceutical Preparations
Location
1000 Spring St, Silver Spring, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 485 % -48.2%
Quick Ratio 15.8 % -46%
Debt-to-equity 21.9 % -16.1%
Return On Equity 18.7 % +20.8%
Return On Assets 15.4 % +25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.4M shares -5.32%
Common Stock, Shares, Outstanding 44.2M shares -5.34%
Entity Public Float 9.14B USD -13.2%
Common Stock, Value, Issued 700K USD 0%
Weighted Average Number of Shares Outstanding, Basic 47M shares +1.51%
Weighted Average Number of Shares Outstanding, Diluted 49.7M shares +0.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.5B USD +26.1%
Research and Development Expense 429M USD +27.4%
Costs and Expenses 1.24B USD +23.5%
Operating Income (Loss) 1.26B USD +28.8%
Nonoperating Income (Expense) 124M USD +464%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.38B USD +47.9%
Income Tax Expense (Benefit) 331M USD +60.8%
Net Income (Loss) Attributable to Parent 1.05B USD +44.2%
Earnings Per Share, Basic 22.4 USD/shares +40.9%
Earnings Per Share, Diluted 21.1 USD/shares +42.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.25B USD +7.56%
Marketable Securities, Current 1.46B USD -14.3%
Accounts Receivable, after Allowance for Credit Loss, Current 307M USD +128%
Inventory, Net 120M USD +17.3%
Other Assets, Current 113M USD +22.5%
Assets, Current 3.25B USD +1.74%
Deferred Income Tax Assets, Net 396M USD +23.1%
Property, Plant and Equipment, Net 1.07B USD +19.8%
Operating Lease, Right-of-Use Asset 12.2M USD
Goodwill 33.7M USD +20.4%
Other Assets, Noncurrent 169M USD +35.8%
Assets 6.5B USD +2.35%
Accounts Payable, Current 5.6M USD +36.6%
Employee-related Liabilities, Current 72.9M USD +9.62%
Accrued Liabilities, Current 292M USD +29.5%
Liabilities, Current 861M USD +165%
Other Liabilities, Noncurrent 96.5M USD -1.73%
Liabilities 1.16B USD -5.37%
Accumulated Other Comprehensive Income (Loss), Net of Tax -15.6M USD +59.8%
Retained Earnings (Accumulated Deficit) 6.33B USD +19.9%
Stockholders' Equity Attributable to Parent 5.34B USD +4.2%
Liabilities and Equity 6.5B USD +2.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 377M USD +0.45%
Net Cash Provided by (Used in) Financing Activities -1.07B USD -2298%
Net Cash Provided by (Used in) Investing Activities 735M USD
Common Stock, Shares Authorized 245M shares 0%
Common Stock, Shares, Issued 74.1M shares +1.07%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 43.8M USD -78.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.25B USD +7.56%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.6M USD -3.82%
Deferred Tax Assets, Valuation Allowance 30.8M USD +37.5%
Deferred Tax Assets, Gross 468M USD +19.7%
Operating Lease, Liability 12.2M USD
Depreciation 52.9M USD +3.32%
Payments to Acquire Property, Plant, and Equipment 38.2M USD -7.51%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.07B USD +44.4%
Lessee, Operating Lease, Liability, to be Paid 32.8M USD +3.47%
Property, Plant and Equipment, Gross 1.52B USD +17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.3M USD +22.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.7M USD +20.5%
Deferred Income Tax Expense (Benefit) -64.4M USD -26.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.2M USD +20%
Deferred Tax Assets, Operating Loss Carryforwards 21.4M USD +125%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -44.3M USD +1.12%
Current Income Tax Expense (Benefit) 354M USD +29.1%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 24.1M USD +58.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.2M USD +20%
Current State and Local Tax Expense (Benefit) 66.6M USD +45.4%
Current Federal Tax Expense (Benefit) 287M USD +25.8%
Amortization of Intangible Assets 300K USD +200%
Depreciation, Depletion and Amortization 15M USD +12.8%
Deferred Tax Assets, Net of Valuation Allowance 437M USD +18.6%
Share-based Payment Arrangement, Expense 77.1M USD -33.2%
Deferred State and Local Income Tax Expense (Benefit) -20.1M USD -235%
Interest Expense 58.8M USD +41.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%